Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Hanson

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Genes|September 28, 2021
Investigation and Management of Apparently Sporadic Central Nervous System Haemangioblastoma for Evidence of Von Hippel-Lindau DiseaseHugh Furness, Louay Salfity, Johanna Devereux, et al.
Journal of Medical Genetics|November 19, 2020
Combining evidence for and against pathogenicity for variants in cancer susceptibility genes: CanVIG-UK consensus recommendationsAlice Garrett, Miranda Durkie, Alison Callaway, et al.
The Lancet. Oncology|May 13, 2023
Utility of polygenic risk scores in UK cancer screening: a modelling analysisCatherine Huntley, Bethany Torr, Amit Sud, et al.
European Urology Oncology|December 14, 2019
Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected IndividualsClaire Forde, Derek H K Lim, Yousef Alwan, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 3, 2024
Classification of variants of reduced penetrance in high-penetrance cancer susceptibility genes: Framework for genetics clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group-UK)Alice Garrett, Sophie Allen, Miranda Durkie, et al.
Journal of Genetic Counseling|August 7, 2025
Optimizing risk-reducing surgery and aspirin decision aids for Lynch syndrome carriers using the person-based approach: A think-aloud interview studyKelly Kohut, Kate Morton, Lesley Turner, et al.
British Journal of Haematology|February 6, 2023
Germline predisposition to haematological malignancies: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar and the NHS England Haematological Oncology Working GroupBeverley Speight, Helen Hanson, Clare Turnbull, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 10, 2020
Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trialFaiza Gaba, Sadiyah Robbani, Naveena Singh, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 5, 2024
Management of individuals with heterozygous germline pathogenic variants in ATM: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)Tuya Pal, Katherine R Schon, Esteban Astiazaran-Symonds, et al.
American Journal of Human Genetics|September 9, 2025
Availability of benign missense variant "truthsets" for validation of functional assays: Current status and a systematic approachCharlie F Rowlands, Sophie Allen, Alice Garrett, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Genes|September 28, 2021
Investigation and Management of Apparently Sporadic Central Nervous System Haemangioblastoma for Evidence of Von Hippel-Lindau DiseaseHugh Furness, Louay Salfity, Johanna Devereux, et al.
Journal of Medical Genetics|November 19, 2020
Combining evidence for and against pathogenicity for variants in cancer susceptibility genes: CanVIG-UK consensus recommendationsAlice Garrett, Miranda Durkie, Alison Callaway, et al.
The Lancet. Oncology|May 13, 2023
Utility of polygenic risk scores in UK cancer screening: a modelling analysisCatherine Huntley, Bethany Torr, Amit Sud, et al.
European Urology Oncology|December 14, 2019
Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected IndividualsClaire Forde, Derek H K Lim, Yousef Alwan, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 3, 2024
Classification of variants of reduced penetrance in high-penetrance cancer susceptibility genes: Framework for genetics clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group-UK)Alice Garrett, Sophie Allen, Miranda Durkie, et al.
Journal of Genetic Counseling|August 7, 2025
Optimizing risk-reducing surgery and aspirin decision aids for Lynch syndrome carriers using the person-based approach: A think-aloud interview studyKelly Kohut, Kate Morton, Lesley Turner, et al.
British Journal of Haematology|February 6, 2023
Germline predisposition to haematological malignancies: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar and the NHS England Haematological Oncology Working GroupBeverley Speight, Helen Hanson, Clare Turnbull, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 10, 2020
Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trialFaiza Gaba, Sadiyah Robbani, Naveena Singh, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 5, 2024
Management of individuals with heterozygous germline pathogenic variants in ATM: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)Tuya Pal, Katherine R Schon, Esteban Astiazaran-Symonds, et al.
American Journal of Human Genetics|September 9, 2025
Availability of benign missense variant "truthsets" for validation of functional assays: Current status and a systematic approachCharlie F Rowlands, Sophie Allen, Alice Garrett, et al.
Pageof 9